Publications

Research publications

Bold = first or co-first authorship · # equal contribution · * corresponding author

2026

  1. Jia K#, Chen Y#, Dai D#, Xie Y, Peng H, Cao Y, Zou H, Qiu C, Tan Y, Zhang X, Lu Z, Yin X*, Peng Z*, Li J*, Shen L*

    Impact of Helicobacter pylori infection on gut and intratumoral microbiome and its association with immunotherapy response in gastrointestinal cancer

    BMC Medicine, 2026 Jan 12; 24(1): 79.

2025

  1. Chen Y#, Jia K#, Xie Y#, Yuan J, Liu D, Jiang L, Peng H, Zhong J, Li J, Zhang X, Shen L*

    The current landscape of gastric cancer and gastroesophageal junction cancer diagnosis and treatment in China: a comprehensive nationwide cohort analysis

    Journal of Hematology & Oncology, 2025 Apr 15; 18(1): 42.

  2. Xie Y#, Peng H#, Hu Y#, Jia K#, Yuan J, Liu D, Li Y, Feng X, Li J, Zhang X, Sun Y, Shen L*, Chen Y*

    Immune microenvironment spatial landscapes of tertiary lymphoid structures in gastric cancer

    BMC Medicine, 2025 Feb 4; 23(1): 59.

2024

  1. Chen Y#, Jia K#, Chong X, Xie Y, Jiang L, Peng H, Liu D, Yuan J, Li Y, Feng X, Sun Y, Li J, Zhang X*, Shen L*

    Implications of PD-L1 expression on the immune microenvironment in HER2-positive gastric cancer

    Molecular Cancer, 2024 Aug 20; 23(1): 169.

  2. Jia K#, Chen Y#, Xie Y#, Wang X, Hu Y, Sun Y, Cao Y, Zhang L, Wang Y, Wang Z, Lu Z, Li J, Zhang X, Shen L*

    Helicobacter pylori and immunotherapy for gastrointestinal cancer

    The Innovation, 2024 Jan 8; 5(2): 100561.

2023

  1. Jia K#, Chen Y#, Xie Y, Chong X, Li Y, Wu Y, Yuan J, Li Y, Feng X, Hu Y, Sun Y, Gong J, Zhang X, Li J, Shen L*

    Multidimensional immune profiling in Gastric Cancer Multiplex Immunohistochemistry Atlas from Peking University Cancer Hospital project informs PD-1/PD-L1 blockade efficacy

    European Journal of Cancer, 2023 Aug; 189: 112931.

  2. Jiang F#, Jia K#, Chen Y, Ji C, Chong X, Li Z, Zhao F, Bai Y, Ge S, Gao J, Zhang X, Li J, Shen L*, Zhang C*

    ANO1-Mediated Inhibition of Cancer Ferroptosis Confers Immunotherapeutic Resistance through Recruiting Cancer-Associated Fibroblasts

    Advanced Science, 2023 Aug; 10(24): e2300881.

2022

  1. Jia K#, Chen Y#, Sun Y, Hu Y, Jiao L, Ma J, Yuan J, Qi C, Li Y, Gong J, Gao J, Zhang X, Li J, Zhang C*, Shen L*

    Multiplex immunohistochemistry defines the tumor immune microenvironment and immunotherapeutic outcome in CLDN18.2-positive gastric cancer

    BMC Medicine, 2022 Jul 11; 20(1): 223.

  2. Chen Y#, Jia K#, Sun Y#, Zhang C#, Li Y, Zhang L, Chen Z, Zhang J, Hu Y, Yuan J, Zhao X, Li Y, Gong J, Dong B, Zhang X, Li J, Shen L*

    Predicting response to immunotherapy in gastric cancer via multi-dimensional analyses of the tumour immune microenvironment

    Nature Communications, 2022 Aug 18; 13(1): 4851.

2020

  1. Jia K, Wu Y, Huang J, Chen J, Wei H, Wu H

    Wide-ranging analysis of survival-related alternative splicing events in invasive breast carcinoma

    Oncology Letters, 2020 Aug; 20(2): 1866–1878.

2019

  1. Jia K, Wu Y, Huang J, Wu H

    Survival-Associated Alternative Splicing Events in Pan-Renal Cell Carcinoma

    Frontiers in Oncology, 2019 Nov 27; 9: 1317.

  2. Jia K, Wu Y, Ju J, Wang L, Shi L, Wu H, Jiang K, Dong J

    The identification of gene signature and critical pathway associated with childhood-onset type 2 diabetes

    PeerJ, 2019 Feb 6; 7: e6343.